Stem Cell Treatment & Research Institution
|Cell Type||Osteocyte differentiated from nEPS(pluripotent stem cell)|
|Reprogramming Method||Epigenetics by STC-F002|
|Species||Homo sapiens, human|
|Origin||Mesenchymal stem cell derived from umbilical cord|
|Shipping information||Distributed frozen (volume : 1mL)|
STRI became the world’s first commercial provider of human osteoblast cell differentiated from human pluripotent stem cell (nEPS) without side effect and services.
This osteoblast is derived from Mesenchymal stem cells (MSC) isolated from umbilical cords of healthy donor